
NASDAQHealthcareBiotechnology
Latest quote
$14.70
−$0.545 · -3.57%
Mentari Therapeutics, Inc. is a biotechnology company, which engages in developing therapies for migraine prevention. Its portfolio includes MT-001 and MT-002. The company was founded on June 13, 2025 and is headquartered in Waltham, MA.
Previous close
$14.70
−$0.545 · -3.57%
Regular session · ET · Market data may be delayed.
Mentari Therapeutics, Inc. is a biotechnology company, which engages in developing therapies for migraine prevention. Its portfolio includes MT-001 and MT-002. The company was founded on June 13, 2025 and is headquartered in Waltham, MA.
Day range
Current $14.70
52-week range
Current $14.70
Regular session · ET · Market data may be delayed.
Mentari Therapeutics, Inc. is a biotechnology company, which engages in developing therapies for migraine prevention. Its portfolio includes MT-001 and MT-002. The company was founded on June 13, 2025 and is headquartered in Waltham, MA.
Day range
Current $14.70
52-week range
Current $14.70
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 3.18B USD | 4.94M USD | 4.6M USD | 4.14M USD | 1.09M USD |
| Cost of goods sold | 2.47B USD | 3.24M USD | 3.5M USD | 2.73M USD | 545.89K USD |
| Gross profit | 709.84M USD | 1.71M USD | 1.1M USD | 1.4M USD | 543.55K USD |
| Research and development | 15.13M USD | 2.85M USD | 3.22M USD | 3.73M USD | 7.28M USD |
| Selling, general, and administrative | 1.88B USD | 6.56M USD | 5.8M USD | 5.85M USD | 6.87M USD |
| Operating expenses | 9.19M USD | 9.62M USD | 9.24M USD | 9.78M USD | 14.34M USD |
| Interest income | 244.97K USD | 156.54K USD | 721.97K USD | 652.37K USD | 123.72K USD |
| Interest expense | 10.7K USD | 373.11K USD | — | — | — |
| Depreciation and amortization | 708.36K USD | 534.73K USD | 604.52K USD | 596K USD | 511.79K USD |
| Operating income | −9.9M USD | −7.92M USD | −8.13M USD | −8.38M USD | −13.79M USD |
| Net income | −12.56M USD | −8.16M USD | −7.68M USD | −7.95M USD | −18.6M USD |
Company facts updated Nov 22, 2026.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.